Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel agents investigated for fibrosis

Oct. 7, 2014

Researchers at Agios Pharmaceuticals patent novel agents for cancer and anemia

Oct. 7, 2014

Oryzon Genomics patents novel DDR1 antibodies for cancer

Oct. 7, 2014

Novartis prepares new IDH inhibitors for cancer

Oct. 6, 2014

BioMarin Pharmaceutical presents novel HDAC inhibitors

Oct. 6, 2014

Bristol-Myers Squibb reports new KCNA5 channel blockers for arrhythmia

Oct. 6, 2014

U.S. investigators synthesize novel anti-C. difficile antibodies

Oct. 6, 2014

AbbVie divulges novel PDE10A inhibitors

Oct. 6, 2014

Novel IRAK-4 inhibitors disclosed by Biogen Idec

Oct. 6, 2014

Boehringer Ingelheim patent discloses novel DPP-I inhibitors

Oct. 3, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...